Deliver on the promise
of regenerative medicine
Address the critical challenges of an aging population and escalating healthcare costs
Address the critical challenges of an aging population and escalating healthcare costs
Accelerated Biosciences was formed in 2014 to commercialize the hTSC that was isolated in 2003 through a salpingectomy procedure to treat an ectopic pregnancy. We have since sourced 20+ cell lines and created GMP-grade materials.
Our robust patent portfolio offers global freedom-to-operate to our partners for our hTSC and derived platforms.
We also have developed know-how and formed strategic partnerships with global CROs and CDMOs to assist our partners in accelerating their paths to clinical success.
Our starting materials and genetically engineered platforms are based on our hTSC. We purposely worked to accentuate the natural qualities of the hTSC to create the best starting materials that could accelerate therapeutic product developments.
We continue to expand the hTSC ecosystem with our partners to improve platform capabilities and address more therapeutic modalities.
Accelerated Biosciences is led by a seasoned management team and renowned advisors from academia, government and industry. We have deep industry relationships and decades of experience.
We are ready to share our hTSCs with you to help you accelerate your research and product development.
Partner with Us
